ev3 Inc.·4

Jan 10, 10:47 AM ET

WILDER THOMAS C III 4

4 · ev3 Inc. · Filed Jan 10, 2006

Insider Transaction Report

Form 4
Period: 2006-01-06
WILDER THOMAS C III
President , Neurovascular Div.
Transactions
  • Award

    Common Stock

    2006-01-06+1,0741,074 total
  • Award

    Common Stock Option

    2006-01-06+119,072119,072 total
    Exercise: $4.25Exp: 2012-08-30Common Stock (119,072 underlying)
  • Award

    Common Stock Option

    2006-01-06+42,86642,866 total
    Exercise: $11.24Exp: 2013-07-29Common Stock (42,866 underlying)
Footnotes (4)
  • [F1]Received in exchange for 2,256 shares of Micro Therapeutics, Inc. common stock in connection with the merger between Micro Therapeutics, Inc. and a wholly-owned subsidiary of the issuer (the "Merger"). On the effective date of the Merger, the closing price of Micro Therapeutics, Inc. common stock was $6.64 per share and the closing price of issuer common stock was $14.00 per share.
  • [F2]Received in the Merger in exchange for an option to purchase 250,000 shares of Micro Therapeutics, Inc. common stock for $2.02 per share, which provided for vesting in the amount of 25% on August 30, 2003, with the remaining vesting in thirty-six equal monthly installments thereafter. Vesting continues as originally scheduled.
  • [F3]Received in the Merger in exchange for an option to purchase 90,000 shares of Micro Therapeutics, Inc. common stock for $5.35 per share, which provided for vesting in forty-eight equal monthly installments beginning July 29, 2003. Vesting continues as originally scheduled.
  • [F4]Received in the Merger in exchange for an option to purchase 250,000 shares of Micro Therapeutics, Inc. common stock for $3.84 per share, which provided for vesting in forty-eight equal monthly installments beginning January 10, 2005. Vesting continues as originally scheduled.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT